학술논문
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome
Document Type
Article
Author
Koziolek, Michael; Bramlage, Carsten Paul; Weber, Frauke; Albrecht-Nock, Tanja; Sonntag, Joseph; Frese, Jenny; Kettwig, Matthias; Hilgers, Reinhard; Hansen, Matthias; Wedekin, Mirja; Meyer, Nicole; Klaiber, Susanne; Gessner, Michaela; Liebau, Max; Vogt-Weigeldt, Anne-Kristin; Jungraithmayr, Therese; Ponsel, Sabine; Jacoby, Ulrike; Konrad, Martin; Kranz, Brigitta; Koenig, Jens; Loechtermann, Lisa; Pohl, Michael; Husain, Ralf; Mueller, Katrin; Thumfart, Julia; Schalk, Gesa; Feldkoetter, Markus; Schmidt, Sabine; Sauerstein, Katja; Muschiol, Evelin; Billing, Heiko; Wilkening, Frauke; Gross, Oliver; Tönshoff, Burkhard; Weber, Lutz T.; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Zappel, Hildegard; Hoyer, Peter; Staude, Hagen; König, Sabine; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Hoecker, Britta; Ehren, Rasmus; Lerch, Christian; Kashtan, Clifford E.; Harden, Markus; Boeckhaus, Jan; Friede, Tim
Source
In Kidney International June 2020 97(6):1275-1286
Subject
Language
ISSN
0085-2538